Grifols SA

GRF.P

Company Profile

  • Business description

    Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

  • Contact

    Avinguda de la Generalitat, 152-158
    Parc de Negocis Can Sant Joan
    Sant Cugat del Valles
    Barcelona08174
    ESP

    T: +34 935710500

    E: [email protected]

    https://www.grifols.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    25,247

Stocks News & Analysis

stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,311.90125.801.37%
CAC 408,666.6352.810.61%
DAX 4026,202.35201.040.77%
Dow JONES (US)54,169.49991.081.86%
FTSE 10010,879.3821.680.20%
HKSE25,852.92156.48-0.60%
NASDAQ26,602.05688.162.66%
Nikkei 22563,957.53202.630.32%
NZX 50 Index13,903.46128.530.93%
S&P 5007,742.64142.141.87%
S&P/ASX 2009,145.80122.801.36%
SSE Composite Index3,822.2812.620.33%

Market Movers